7/27/2010

ALPCO Diagnostics Launches First Commercially Available Sclerostin ELISA in the U.S.

ALPCO Diagnostics recently launched an ELISA specific for measuring human sclerostin in serum and plasma. ...(more)

6/1/2010

ALPCO Diagnostics Prepares for Launch of Unique Immunoassays
ALPCO Diagnostics announces the recent hiring of Leon F. Hebert Jr., Ph.D. As ALPCO’s new Diabetes and Obesity Product Manager, ...(more)

3/22/2010

US patent granted for the Multimeric Adiponectin ELISA.
A growing body of research supports the use of adiponectin as an indicator of metabolic syndrome and type II diabetes progression. While ...(more)

1/26/2010

ALPCO Launches Rat and Mouse Proinsulin ELISA Kits.
ALPCO Diagnostics has developed two new low-sample volume ELISAs for the quantitative analysis of total proinsulin (I and II) in rats and mice. ...(more)

12/9/2009

ALPCO Diagnostics and BioPorto Diagnostics enter into distribution partnership

ALPCO Diagnostics has taken on the responsibility to promote and sell BioPorto Diagnostics immunoassays on the ...(more)